🔎 Trials Near Me

Gara Jalqabaatti › Dhukkubbee Onkoloo Interstishiyali › Arizona

Qorannoo klinikaalii Dhukkubbee Onkoloo Interstishiyali Arizona keessatti

Qorannoo 13 Dhukkubbee Onkoloo Interstishiyali f Arizona keessatti hirmaatuu jiru.

Magaalota Arizona keessatti

Takkalaa qorannoo (Ingiliffa)

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Arizona Heart Rhythm Center, Phoenix
  • University of Arizona, Tucson
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT05798923

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • USA027, Phoenix
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07179380

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Scottsdale
  • GSK Investigational Site, Scottsdale
  • GSK Investigational Site, Tucson
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05878717

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

  • Phoenix, Phoenix
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07473700

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Banner University Medical Center, Phoenix
  • Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute, Phoenix
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06911632

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix
  • Arizona Pulmonary Specialists, Ltd., Scottsdale
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Banner Health - University Medical Center Phoenix, Phoenix
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06388421

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Arizona, Tucson
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 21 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Arizona Pulmonary Specialists, Phoenix
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07175038

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Banner University Medical Center Phoenix Lung Institute, Phoenix
  • Norton Thoracic Institute, Phoenix
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT05943535

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

  • Arizona Pulmonary Specialists, Phoenix
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT06129240

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

  • Mayo Clinic in Arizona, Scottsdale
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Bit-2026 · NCT06751069

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • HonorHealth Research Institute, Scottsdale
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 12-Sad-2025 · NCT05975983

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.